MarkWilliamKieranMD

Pediatric Hematology & Oncology • Boston, MA

Pediatric Neuro-Oncology

Associate Professor of Pediatrics, Dana-Farber Cancer Institute

Join to view full profile

Dr. Kieran is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kieran's full profile

Already have an account?

Office
44 Binney St
Rm SW331
Boston, MA 02115
Phone+1 617-632-4907

Fax+1 617-632-4897

Education & Training

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1992 - 1995
University of Calgary Faculty of MedicineClass of 1986
University of AlbertaPh.D., Medicine (Immunology), 1983
McMaster UniversityB.Sc., Biochemistry, 1980

Certifications & Licensure

MA State Medical License 1992 - 2026
PA State Medical License 2019 - 2024
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Boston Magazine Castle Connolly, 2008-2015
America's Top Doctors Castle Connolly, 2008-2015
America's Top Doctors for Cancer Castle Connolly, 2005-2015
Top Doctors for Cancer Newsweek Magazine, 2015
Parent and Family Award Children’s Cancer Hospital Egypt, 2015
Nominated, Schwartz Compassionate Care Giver Award Dana-Farber Cancer Institute, 2014
Science and Medicine Award Progeria Research Foundation, 2014
America’s Top Physicians Showmark, 2014-2015
Marquis Who’s Who in America Marquis, 2013-2015
Nominated, 2013 Dean’s Community Service Faculty Award Harvard Medical School, 2012
Nominated, Excellence in Mentoring Award Harvard Medical School, 2012
Nomination for Mentor of the Year Award, Postdoc and Graduate Student Affairs Office Harvard Medical School, 2012
Stephen Sallan Leadership Award in Pediatric Oncology Dana –Farber Cancer Institute, 2011
Marquis Who’s Who in Medicine and Healthcare Marquis, 2011
Nominated, Schwartz Compassionate Care Giver Award Dana –Farber Cancer Institute, 2010
Mill Foundation for Kid’s Above and Beyond Award Foundation Awards, 2010
National Brain Tumor Society Billy Grey Research Chairman Award National Brain Tumor Society, 2010
Certificate of Appreciation in Teaching University of Constantine, Algeria, 2010
Appreciation Award, Excellence Award Children's Cancer Hospital Egypt Egyptian Society of Neurosurgeons, 2009
Top Doctors in Boston Boston Magazine, 2009
America’s Top Doctor for Cancer Castle Connolly, 2008
Triple Winner Award Stop & Shop Boston, 2006
Letter of Appreciation Seoul National University, Seoul Korea, 2006
Voted an America’s Top Cancer Doctor 2006
2nd International Germ Cell Meeting Award Children's Hospital Los Angeles, 2002
Nick Palmer Lecture Award ISPNO, 2002
Joseph Albert Award of Excellence, Clinical training award to study and HMS, Department of Obstetrics and Gynecology 1985
Ian Watson Immunology Award, Lecturing stipend in Europe 1984
Part-time fellowship, Alberta Heritage foundation for medical research Alberta Heritage Foundation, 1983
Studentship, Alberta Heritage foundation for medical research Alberta Heritage Foundation, 1981
Special Studentship, Department of Biochemistry University of Alberta, 1979
Scholarship for Academic Achievement McMaster University, 1978
Super Doctor SuperDoctors.com
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

SU5416 in Treating Children With Recurrent or Progressive Brain Tumors Start of enrollment: 2000 Aug 01
Terminated
Phase 1
SCH 66336 in Treating Children With Recurrent or Progressive Brain Tumors Start of enrollment: 2002 Jan 01
Completed
Phase 1
Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT Start of enrollment: 2003 Feb 01
Completed
Phase 2
Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma Start of enrollment: 2002 Sep 01
Completed
Phase 2
rhEndostatin Protein Involving Pediatric Patients With Cancer Start of enrollment: 2003 Jan 01
Terminated
Phase 1
A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer Start of enrollment: 2001 Jun 01
Completed
Phase 2
A-protein Levels in Adult and Pediatric Brain Tumor Patients Start of enrollment: 1998 Jun 01
Completed
Vinblastine and Methotrexate in Children With Pulmonary Vein Stenosis Start of enrollment: 2000 Mar 01
Completed
Phase 2
Measurement of Angiogenic Related Growth Factors in Urine and Blood From Patients With Pulmonary Vein Stenosis Start of enrollment: 2000 Aug 01
Terminated
AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors Start of enrollment: 2006 Mar 01
Completed
Phase 1
Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer Start of enrollment: 2005 Jan 01
Completed
Phase 2
Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria Start of enrollment: 2007 May 01
Completed
Phase 2
A Pilot Study of 18F-FLT in Pediatric Patients With Central Nervous System (CNS) Tumors Start of enrollment: 2008 Mar 01
Terminated
Phase 1
A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors Start of enrollment: 2010 Oct 01
Completed
Phase 1
Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas Start of enrollment: 2009 Jun 01
Completed
Phase 2
Pilot Study Using Avastin and Gleevec to Treat the Progression of Intraluminal Pulmonary Vein Stenosis Start of enrollment: 2008 Oct 01
Completed
Phase 1, Phase 2
Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria Start of enrollment: 2009 Aug 01
Active, not recruiting
Phase 2
External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas Start of enrollment: 2009 Oct 30
Completed
Phase 2
Everolimus for Children With NF1 Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomas Start of enrollment: 2010 Jul 10
Completed
Phase 2
Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG) Start of enrollment: 2011 Sep 01
Terminated
Phase 2
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors Start of enrollment: 2011 Feb 09
Completed
Phase 1, Phase 2
Tolerability Study of Xerecept® in Pediatric Patients Start of enrollment: 2010 Jun 01
Terminated
Phase 1, Phase 2
A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB) Start of enrollment: 2013 May 06
Completed
Phase 2
Phase 2 Study of Bevacizumab in Children and Young Adults With NF 2 and Progressive Vestibular Schwannomas Start of enrollment: 2013 May 15
Completed
Phase 2
Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults Start of enrollment: 2014 Jun 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

95 citations
Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells.
Claire M. Sauvageot, Jessica Weatherbee, Santosh Kesari, Susan Elizabeth Winters, Jessica W. Barnes
Neuro-Oncology. 2009-04-01
494 citations
Challenges to curing primary brain tumours
Kenneth Aldape, Kevin M. Brindle, Louis Chesler, Rajesh Chopra, Amar Gajjar
Nature Reviews. Clinical Oncology. 2019-02-07
222 citations
Clinical, Radiologic, Pathologic, and Molecular Characteristics of Long-Term Survivors of Diffuse Intrinsic Pontine Glioma (DIPG): A Collaborative Report From the Inte...
Lindsey M. Hoffman, Sophie E. M. Veldhuijzen van Zanten, Niclas Colditz, Joshua J Baugh, Brooklyn Chaney
Journal of Clinical Oncology. 2018-05-10

Journal Articles

Immunophenotyping of Pediatric Brain Tumors: Correlating Immune Infiltrate with Histology, Mutational Load, and Survival and Assessing Clonal T Cell Response
Isaac H Solomon, Mark W Kieran, Gabriel K Griffin, Pratiti Bandopadhayay, Jerome Ritz, Ashley S Plant, Keith L Ligon, Glenn Dranoff, Journal of Neuro-Oncology
The role of the farnesyltransferase inhibitor lonafarnib in the treatment of progeria
Kieran MW, Gordon LB, Kleinman ME, Expert Opin Orphan Drugs, 1/1/2014
Inhibition of tumor angiogenesis by oral etoposide
Panigrahy D, Kaipainen A, Butterfield CE, Chaponis DM, Laforme AM, Folkman J, Kieran MW, Experimental and Therapeutic Medicine, 1/1/2010
PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition
Panigrahy D, Kaipainen A, Huang S, Butterfield CE, Barnes CM, Fannon M, Laforme AM, Chaponis DM, Folkman J, Kieran MW, Proc Natl Acad Sci USA, 1/1/2008
Phase I clinical trial of celingitide in children with refractory brain tumors: Pediatric Brain Tumor Consortium Study PBTC-012
MacDonald TJ, Stewart CF, Kocak M, Goldman S, Ellenbogen RG, Phillips P, Lafond D, Poussaint TY, Kieran MW, Boyett JM, Kun LE, J Clin Oncol, 1/1/2008
Basement membrane derived fibulin-1 and fibulin-5 function as angiogenesis inhibitors and suppress tumor growth
Xie L, Palmsten K, Macdonald B, Kieran MW, Potenta S, Vong S, Kalluri R, Exp Biol Med, 1/1/2008
Type IV collagen a6 chain-derived non-collagenous domain 1 (a6(IV)NC1) inhibits angiogenesis and tumor growth
Mundel TM, Yliniemi AM, Maeshima Y, Sugimoto H, Kieran M, Kalluri R, Intern J Cancer, 1/1/2008
Brainstem lesions in neurofibromatosis type I
Ullrich NJ, Raja AI, Irons MB, Kieran MW, Goumnerova L, Neurosurgery, 1/1/2007
NF1 plexiform neurofibroma growth rate by volumetric MRI: Relationship to age and body weight
Dombi ED, Solomon J, Gillespie AJ, Fox e, Balis FM, Patronas N, Korf BR, Babovic-Vuksanovic D, Packer RJ, Belasco J, Goldman S, Jakacki R, Kieran M, Steinberg SM, Wide..., Neurology, 1/1/2007
Phase I trial of imatinib in children with newly diagnosed brainstem and recurrent malignant gliomas: A Pediatric Brain Tumor Consortium Report
Pollack IF, Jakacki RI, Blaney SM, Hancock ML, Kieran MW, Phillips P, Kun LE, Friedman H, Packer R, Banerjee A, Geyer JR, Goldman S, Poussaint TY, Krasin MJ, Yang Y, H..., Neuro-Oncol, 1/1/2007
PPARa deficiency in inflammatory cells suppresses tumor growth
Kaipainen A, Kieran MW, Huang S, Butterfield C, Bielenberg D, Mostoslavsky G, Mulligan R, Folkman J, Panigrahy D, PLoS, 1/1/2007
Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib (Sarasar - SCH66336) given twice daily to pediatric patients with advanced centr...
Kieran MW, Packer RJ, Onar A, Blaney SM, Phillips P, Pollack IF, Geyer JR, Gururangan S, Banerjee A, Goldman S, Turner CD, Belasco JB, Broniscer A, Zhu Y, Frank E, Kir..., JCO, 1/1/2007
Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults
Kesari S, Schiff D, Doherty L, Gigas DC, Batchelor TT, Muzikansky A, O'Neill A, Drappatz J, Chen-Plotkin AS, Ramakrishna N, Weiss SE, Levy B, Bradshaw J, Kracher J, La..., Neuro-oncology, 1/1/2007
Phase II study of thalidomide and radiation in children with newly diagnosed brain stem glioma and glioblastoma multiforme
Turner CD, Chi S, Marcus KJ, MacDonald T, Packer RJ, Young Poussaint T, Vajapeyam S, Ullrich N, Goumnerova L, Scott RM, Briody C, Chordas C, Zimmerman MA, Kieran, MW, J Neuro-Onc, 1/1/2007
Moyamoya following cranial irradiation for primary brain tumors in children
Ullrich NJ, Robertoson R, Kinnamon DD, Scott RM, Kieran MW, Turner CD, Chi SN, Goumnerova L, Proctor M, Tarbell NJ, Marcus KJ, Pomeroy SL, Neurology, 1/1/2007
Progeria: New approaches to Progeria
Kieran MW, Gordon L, Kleinman M, Pediatrics, 1/1/2007
Pulmonary vein stenosis: expression of receptor tyrosine kinases by lesional cells
Riedlinger WFJ, Juraszek AL, Jenkins KJ, Nugent AW, Balasubramanian S, Calicchio ML, Kieran MW, Collins T, Cardiovascular Pathology, 1/1/2006
A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of C...
Cornetta K, Croop J, Dropcho E, Abonour R, Kieran MW, Kreissman S, Reeves L, Erickson LC, Williams DA, Cancer Gene Ther, 1/1/2006
AAL881, a novel small molecule inhibitor of RAF and vascular endothelial growth factor receptor activites, blocks the growth of malignant gliomas
Sathornsumetee S, Hjelmeland AB, Keir ST, McLendon RE, Batt D, Ramsey T, Yusuff N, Rasheed BK, Kieran MW, Laforme A, Bigner DD, Friedman HS, Rich JN, Cancer Res, 1/1/2006
PPAR? as a therapeutic target for tumor angiogenesis and metastasis
Panigrahy D, Huang S, Kieran, MW, Kaipainen A, Cancer Biol & Therapy, 1/1/2005
Continuous Remission of Newly Diagnosed and Relapsed Central Nervous System Atypical Teratoid/Rhabdoid Tumor
Zimmerman MA, Goumnerova LC, Proctor M, Scott RM, Marcus M, Pomeroy SL, Turner C, Chi S, Chordas C, Kieran MW, J Neuro-Oncol, 1/1/2005
Diencephalic Syndrome: A Cause of Failure to Thrive and a Model of Partial Growth Hormone Resistance
Fleischman A, Brue C, Young Poussaint T, Kieran MW, Pomeroy SL, Goumnerova L, Scott RM, and Cohen LE, Pediatrics, 1/1/2005
Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors: a pediatric brain tumor consortium study (...
Blaney SM, Boyett J, Friedman H, Gajjar A, Geyer R, Horowtiz M, Hunt D, Kieran M, Kun L, Packer R, Phillips P, Pollack IF, Prados M, Heideman R, J Clin Oncol, 1/1/2005
Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors
Sund M, Hamano Y, Sugimoto H, Sudhakar A, Soubasakos M, Yerramalla U, Benjamin LE, Lawler J, Kieran M, Shah A, Kalluri R, Proc Natl Acad Sci, 1/1/2005
Don't throw out the baby with the bathwater!
Kamen B, Kieran M, J Pediatr Hematol Oncol, 1/1/2005
Join now to see all

Books/Book Chapters

Posterior Fossa Tumors in Children.
Chapter: Genetics of Cerebellar Low-Grade Astrocytomas.
Kieran MWEditors: Ozek, Cinalli, Maixner and Sainte-Rose.Springer, Switzerland2015
Oncology of Infancy and Childhood.
Chapter: Tumors of the Brain and Spinal Cord
Kieran MWEditors: Orkin & Nathan & Ginsburg & Look & Fisher & Lux.Sanders Elsevier, Philadelphia, PA2014
Angiogenesis - Biology and Pathology.
Chapter: The VEGF Pathway in Cancer and Disease: Responses, Resistance and the Path Forward.
Kieran MWEditors: Cold Spring Harbor Perspectives in Medicine.Cold Spring Harbor Laboratory Press, New York, NY2012
ASCO Educational Book
Chapter: Identification of novel biologic targets in the treatment of newly diagnosed diffuse intrinsic pontine glioma.
Kieran MWEditors: Govindan R.American Society of Clinical Oncology, Alexandria, VA2012
Understanding the Journey, A parent’s guide to DIPG.
Chapter: The future of genomics and proteomics in DIPG.
Kieran MWEditors: Ruth Hoffman.American Childhood Cancer Organization2012
Primary Central Nervous System Tumors. Pathogenesis and Therapy.
Chapter: Pediatric Tumors.
Kieran MWEditors: Norden, Reardon and Wen.Humana Press Springer, New York, NY2010
The Progeria Handbook. A Guide for Families & Health Care Providers of Children with Progeria.
Chapter: Drug Treatment Trials.
Kieran MWProgeria Research Foundation2010
Pediatric Brain Tumors.
Kieran MWEditors: Springer Science.2010
Oncology of Infancy and Childhood.
Chapter: Tumors of the Brain and Spinal Cord.
Kieran MWSanders Elsevier, Philadelphia, PA2009
UpToDate Oncology
Chapter: Diffuse pontine gliomas.
Kieran MWEditors: Rose RB.UpToDate, Waltham, MA2007
UpToDate Oncology
Chapter: Focal Brain Stem Gliomas.
Kieran MWEditors: Rose RB.UpToDate, Waltham, MA2007
American Society of Clinical Oncology (ASCO)
Chapter: Rare brain tumors in pediatrics: An update on germ cell tumors, atypical teratoid/rhabdoid tumors, and choroids plexus tumors.
Kieran MW2006
American Society of Clinical Oncology (ASCO) Educational Book.
Chapter: The emerging role of Biologic and anti-angiogenic therapy in the management of Pediatric Brain Tumors.
Kieran MW2005
Angiogenesis in Brain Tumors
Chapter: Anti-angiogenic Chemotherapy in Central Nervous System Tumors.
Kieran MWEditors: Ed Kirsch M and Black, PM.Klewer Academic Publishers2003
UpToDate Oncology
Chapter: Ependymomas.
Kieran MWEditors: Rose RB.UpToDate, Waltham, MA2001
Induction of hematopoiesis during embryogenesis in the zebrafish.
Kieran MWEditors: Stamatoyannopoulos.Intercept Publishers, Andover, UK1996
Ontogeny of hematopoiesis. Aplastic anemia.
Chapter: The zebrafish: a new model for studying embryonic hematopoiesis.
Kieran MWEditors: Coulombel.Colloque INSERM/John Libbey Eurotext, Paris1995
Tumor invasion and metastasis.
Chapter: A new model for leukemia-lymphoma metastasis: Differential growth and rejection of murine lymphoid-leukemia cell lines in the bone marrow.
Kieran MWEditors: Milas.Raven Press1984
Join now to see all

Abstracts/Posters

A feasibility and randomized phase II study of vorinostat, bevacizumab, or temozolomide during radiation followed by maintenance chemotherapy in newly-diagnosed pediat...
Hoffman LM, Geller G, Leach J, Boue D, Drissi R, Chen L, Panandiker A, Chow L, Haas-Kogan D, Jogal S, Nelson M, Jakacki R, Kieran MW, Cohen K, Pollack I, Gajjar A, Fou..., SNO Pediatric Basic and Translational Meeting, San Diego, CA, 1/7/2015
Phase 1 study of dabrafenib in pediatric patients (pts) with relapsed or refractory BRAF V600E high- and low-grade gliomas (HGG, LGG), Langerhans cell histiocytosis (L...
Kieran MW, Hargrave D, Cohen K, Aerts I, Dunkel IJ, Hummel TR, Jimenez I, Pearson A, Pratilas C, Whitlock J, Bouffet E, Shen V, Broniscer A, Bertozzi A-I, Sandberg J, ..., ASCO, Chicago, IL, 1/1/2015
Intravascular fasciitis-like proliferation characterizes pediatric pulmonary vein stenosis: clinicopathologic analysis of 213 samples.
Kovach A, Magcalas P, Ireland C, McEnany K, Kieran M, Jenkins K, Baird C, Vargas SO, Pediatr Devel Pathol; Society for Pediatric Pathology, 1/1/2015
Maresin 1: a potent endogenous anti-inflammatory and pro-resolving inhibitor of primary tumor growth and metastasis.
Dayna K. Mudge, Mark W. Kieran, Diane R. Bielenberg, Ofra Benny, Jesmond Dali, Sui Huang, Charles N. Serhan, Dipak Panigrahy, 15th International Winter Eicosanoid Conference, Baltimore, MD, 1/9/2014
Epoxyeicosanoid regulation of tumor lymphangiogenesis.
Jessica A. Casper, Dayna K. Mudge, Diane R. Bielenberg, Bruce D. Hammock, Mark W. Kieran, Dipak Panigrahy, 15th International Winter Eicosanoid Conference, Baltimore, MD, 1/9/2014
Increased Sensorineural Hearing Sensitivity in Children with Progeria During Lonafarnib Treatment.
Homira Osman, Brian Fligor, Leslie Gordon, Monica Kleinman and Mark Kieran, American Auditory Society Scientific and Technology Meeting, Scottsdale, AZ, 1/6/2014
The eicosanoid 20-HETE triggers Ras activation, pancreatic cancer growth and metastasis through inflammatory macrophage signaling.
Yael Gus-Brautbar, Jessica A. Casper, Diane R. Bielenberg, Jennifer Cheng, Birgitta Schmidt, Bruce D. Hammock, Darryl C. Zeldin, Mark W. Kieran, Dipak Panigrahy, AACR, San Diego, CA, 1/4/2014
Automated processing of dynamic contrast enhanced (DCE) T1 permeability perfusion: advanced pharmacokinetic metrics in pediatric brain tumors.
Sridhar Vajapeyam, Kelsey Shannahan, Naira Muradyan, Mark Kieran, Tina Young Poussaint, Radiologic Society of North America (RSNA), Chicago, IL, 1/1/2014
Complete Radiographic Responses in Pediatric Patients with BRAF V600–Positive Tumors Including High Grade Gliomas: Preliminary Results of an Ongoing Phase I/IIa Safety...
Mark W. Kieran, Kenneth J. Cohen, Francois Doz, Ira J. Dunke, Darren R. Hargrave, Trent Ryan Humme, Irene Jimenez, Sarah Leary, Andrew D.J. Pearson, Christine A. Prati..., Pediatric Oncology; American Society Clinical Oncology (ASCO), Chicago, IL, 1/1/2014
Clinical targeted exome-based sequencing for children diagnosed with brain tumors: Initial results of an institute-wide project on personalized medicine.
Pratiti Bandopadhayay, Susan N Chi, Katherine Janeway, Nathan Pinches, Hayley Malkin, Peter E Manley, Liliana Goumnerova, Michael Chang, Shakti Ramkissoon, Mark W Kier..., Society for Neuro-Oncology, Miami, FL, 1/1/2014
Join now to see all

Lectures

Efficacy and safety results from a phase I/IIa study of dabrafenib in pediatric patients with BRAF V600 mutant relapsed refractory low-grade glioma.
2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018
Cancer Biology Seminar Series
Boston, MA - 1/6/2015
BRAF in pediatric cancer.
Chicago, IL - 1/30/2014
Pediatric Neuro-Oncology Seminar Series
Boston, MA - 1/23/2014
ICU Educational Seminar Series
Boston, MA - 1/23/2014
Idaho Pediatric Oncology Team Visit
Boston, MA - 1/22/2014
Neurosciences Lecture; Adult and Pediatric LGG
Boston, MA - 1/17/2014
Update on the Radiologic Assessment in Pediatric Neuro-Oncology
Chicago, IL - 1/13/2014
Update Course on Molecular Therapies.
Trondheim, Norway - 1/12/2014
Update Course on CNS Tumors.
Trondheim, Norway - 1/11/2014
Steering Meeting and RAD001
Washington, DC - 1/6/2014
Survivorship for LGG Kids - Breakthrough Survivorship Research Findings Help Guide Treatment Options
1/5/2014
Medulloblastoma
Annaba, Algeria - 1/2/2014
High-Grade Gliomas
Annaba, Algeria - 1/1/2014
Novel agents in Pediatric Low-Grade Gliomas
Singapore - 1/1/2014
Hematology/Oncology Review
Boston, MA - 1/30/2013
Multidisciplinary Approaches for Treating Pediatric Brain Tumors
1/26/2013
Radiation Oncology Seminar Series
Boston, MA - 1/21/2013
Development Seminar
Boston, MA - 1/12/2013
Treatment of Medulloblastoma
Medical City, Baghdad , Iraq - 1/7/2013
HITO Mexico Brain Tumor Seminar
Boston, MA - 1/6/2013
Treatment of Pediatric Brain Tumors
Medical City, Baghdad , Iraq - 1/6/2013
CPON Review course
Waltham, MA - 1/1/2013
Pediatric Oncology Nursing Course
Boston, MA - 1/1/2013
Review Course for Oncology Fellows
Boston, MA - 1/30/2012
Join now to see all

Other

PhD thesis: Receptor-Acceptor Interactions in Organ Specific Metastases
Kieran MW, University of Alberta, Department of Immunology
1/1/1984
Diffuse pontine glioma
Kieran MW, Marcus KJ
http://www.uptodate.com/contents/diffuse-pontine-glioma
UpToDate, Wolters Kluwer Health - 2012-11-29
Ependymoma
Kieran MW
http://www.uptodate.com/contents/ependymoma
UpToDate, Wolters Kluwer Health - 2013-02-12
Focal brainstem glioma
Kieran MW, Marcus KJ
http://www.uptodate.com/contents/focal-brainstem-glioma
UpToDate, Wolters Kluwer Health - 2012-05-30
Join now to see all

Press Mentions

An Ounce of Prevention: Preoperative Management of Inflammation May Stave off Cancer RecurrencesOctober 17th, 2019
New Targeted Cancer Therapies Prove Successful When Chemo Does NotJanuary 8th, 2019
After a Child's Dire Diagnosis, Hope and Uncertainty at the Frontiers of MedicineDecember 6th, 2018
Join now to see all

Grant Support

Phase II Trial Of Lonafarnib, Pravastatin And Zoledronic Acid In ProgeriaNational Heart, Lung, And Blood Institute2009–2010
Phase I Trial Of Temozolomide And 06-Benzylguanine In Pediatric Patients W/ RecuNational Center For Research Resources2004–2005
Xenogen'S Ivis 100 Imaging System: Tissue EngineeringNational Center For Research Resources2004
Xenogen'S Ivis 100 Imaging System: CardiovascularNational Center For Research Resources2004
Xenogen'S Ivis 100 Imaging System: CancerNational Center For Research Resources2004
Xenogen'S Ivis 100 Imaging SystemNational Center For Research Resources2004
Harvard Pediatric Brain Tumor CenterNational Cancer Institute2000–2003
Pediatric Brain Tumor CenterNational Cancer Institute1999